Bio Blast Pharma (ORPN) Posts Q2 Loss of 10c/Share

Bio Blast Pharma (NASDAQ: ORPN) reported Q2 EPS of ($0.10), $0.01 worse than the analyst estimate of ($0.09).

For earnings history and earnings-related data on Bio Blast Pharma (ORPN) click here.

You May Also Be Interested In

• Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
• Bernstein upgrades Analog Devices on Q3 beat, improving risk-reward
• Walmart (WMT) Tops Q2 EPS by 7c, Beats on Revenue; Offers FY27 EPS Guidance